Search - tctmd.com

Displaying 1 - 20 of 600

Sort: Relevancy | Date

News Daily News

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

Michael O'Riordan

March 13, 2026

News Daily News

AHA Forecast: CV Risk Factors in Women, Girls Headed in Wrong Direction

L.A. McKeown

March 03, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

News Opinion CV Team Dispatch

February 2026 Dispatch for the CV Team

L.A. McKeown

February 18, 2026

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

Caitlin E. Cox

February 02, 2026

News Daily News

Chemo-Induced Vascular Dysfunction More Likely When Breast Cancer Occurs After Menopause

Yael L. Maxwell

January 23, 2026

News Daily News

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

Yael L. Maxwell

January 21, 2026

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

L.A. McKeown

January 16, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Statins Work for Primary Prevention Even in Low-risk Patients With Type 2 Diabetes

Todd Neale

January 05, 2026

News Daily News

Better LDL Control After STEMI Means Less Neoatherosclerosis

Yael L. Maxwell

December 23, 2025

News Daily News

Risk Calculators Miss Many Patients Who Present With First MI

Michael O'Riordan

November 21, 2025

News Daily News

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Yael L. Maxwell

November 10, 2025

News Conference News AHA 2025

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

Caitlin E. Cox

November 08, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Daily News

Evolocumab Wins for Primary Prevention in VESALIUS-CV

L.A. McKeown

October 03, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

Advertisement

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

AHA Forecast: CV Risk Factors in Women, Girls Headed in Wrong Direction

TCTMD’s Top 10 Most Popular Stories for February 2026

February 2026 Dispatch for the CV Team

Side Effects of Statins Might Be Overstated: CTT Collaboration

TCTMD’s Top 10 Most Popular Stories for January 2026

Chemo-Induced Vascular Dysfunction More Likely When Breast Cancer Occurs After Menopause

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

January 2026 Dispatch for the CV Team

JACC Debuts Data Digest on CV Health in the United States

Statins Work for Primary Prevention Even in Low-risk Patients With Type 2 Diabetes

Better LDL Control After STEMI Means Less Neoatherosclerosis

Risk Calculators Miss Many Patients Who Present With First MI

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Evolocumab Wins for Primary Prevention in VESALIUS-CV

TCTMD’s Top 10 Most Popular Stories for September 2025

September 2025 Dispatch for the CV Team

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content